Monday, 25 May 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 25 May 2026
News

Dark Horse climbs Innovation Index

Posted 25 May 2026 AM

Eli Lilly and MSD have again secured first and second position, respectively, on IDEA Pharma’s 2026 Pharmaceutical Innovation Index, with Sanofi skyrocketing up the leaderboard to secure third position.

The Innovation Index ranks 30 companies utilising a range of clinical, regulatory, and commercial metrics, ranging from the corporate level down to individual product decisions and outcomes. It seeks to answer the question: Which of two pharma companies, given the same molecule in early phase, would do better in developing and launching it?

To see the whole article, please login

Popular

Ninth time a Great Place To Work
Ex-Google boss busts pharma silos
Highest paid KOLs revealed
How much MSLs really earn
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home